Ethics/Regulatory

CRISPR/Cas9 U.S. patent board decision appealed

Friday, April 14, 2017

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics announced that The Regents of the University of California, the University of Vienna and Dr. Emmanuelle Charpentier (collectively UC), co-owners of foundational intellectual property relating to CRISPR/Cas9 genome engineering, have appealed to the U.S. Court of Appeals for the Federal Circuit (the Federal Circuit) the decision by the Patent Trial and Appeal Board (PTAB) to terminate the interference between certain CRISPR/Cas9 patent claims owned by UC and patents and patent applications owned by the Broad Institute, Harvard University and the Massachusetts Institute of Technology (collectively Broad).

[Read More]

FDA, Emulate partner on organs-on-chips technology

Wednesday, April 12, 2017

Emulate has entered into a Cooperative Research and Development Agreement (CRADA) with the FDA’s Office of Foods and Veterinary Medicine. Under this multi-year CRADA, Emulate and FDA will collaborate to evaluate and qualify the use of Emulate’s Organs-on-Chips technology as a platform for toxicology testing to meet regulatory evaluation criteria for products—including foods, dietary supplements and cosmetics. The CRADA studies will use Emulate’s Human Emulation System, comprised of Organ-Chips, instrumentation and software apps. The system recreates the natural physiology of specific human tissues and organs, and is designed to provide a predictive model of human response to diseases, medicines, chemicals, and foods with greater precision and detail than other preclinical testing methods, such as cell culture or animal-based experimental testing.

[Read More]

Domestic Research Enhancement Act of 2017 endorsed by many

Tuesday, April 11, 2017

The Domestic Research Enhancement Act of 2017 (H.R. 1234), which modernizes the R&D tax credit to recognize the essential role contract research now plays in the development of new pharmaceuticals, biologics and medical devices, has been introduced by Rep. Pat Meehan (R-PA) and co-sponsors Rep. George Holding (R-NC) and G.K. Butterfield (D-NC).

[Read More]

Science march planned for April 22

Tuesday, April 11, 2017

On Saturday, April 22, the March for Science will take place in more than 400 cities across the globe to celebrate the many scientific advances that have improved the health and well-being of people worldwide. Research!America will be on the ground participating in the Washington, D.C. event, and some of the satellite marches in Los Angeles, California; Oklahoma City, Oklahoma; and Salt Lake City, Utah. 

[Read More]

HealthCarePoint’s mRSI initiative reaches 10-year milestone

Wednesday, April 5, 2017

HealthCarePoint (HCP) has announced that the modified Rankin Scale (mRS) standards are now available to healthcare and clinical research professionals on every continent and in over 12 languages through the BlueCloud Education Network. The achievement marks a 10-year milestone for the company, which is working to standardize healthcare training and certification for healthcare professionals internationally. 

[Read More]